Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Tibone

Sports Medicine Los Angeles, CA Medical Doctor

NPI 1831174523 CMS profile 264778

6801 Park Terrace, 100 & 400, Los Angeles, CA 90045

Open in the dashboard

General payments

$74,314

260 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$75,000

4 holdings reported · through program year 2025

Through program year 2025, James Tibone of Los Angeles, CA is reported in the CMS Open Payments database as having received $74,314 across 260 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $75,000 across 4 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,440 26
2024 General $16,661 44
2023 General $2,910 26
2022 General $16,058 43
2021 General $10,572 44
2020 General $10,054 30
2019 General $14,619 47
2022 Ownership $0 1
2021 Ownership $25,000 1
2020 Ownership $25,000 1
2019 Ownership $25,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Tibone
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to James Tibone were reported at $3,440. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year James Tibone Sports Medicine median Middle half National median
2019 $14,619 $1,176 $199–$4,249 $163
2020 $10,054 $708 $96–$2,890 $114
2021 $10,572 $1,213 $152–$3,994 $132
2022 $16,058 $1,230 $159–$3,998 $149
2023 $2,910 $584 $146–$2,836 $160
2024 $16,661 $628 $163–$3,168 $164
2025 $3,440 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $53,423 171 payments
  2. Saxum Surgical, Inc. $8,400 7 payments
  3. Micromed Inc $5,119 7 payments
  4. Stryker Corporation $3,426 31 payments
  5. Smith+Nephew, Inc. $2,665 28 payments
  6. Abanza Inc. $349 3 payments
  7. Linvatec Corporation $171 1 payment
  8. Pacira Pharmaceuticals Incorporated $152 1 payment
  9. FX Shoulder USA, Inc $124 1 payment
  10. Alpha Orthopedic Systems $117 1 payment
  11. Other $370 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $38,425 4 payments
  2. Education $13,200 11 payments
  3. Travel and Lodging $12,191 52 payments
  4. Food and Beverage $10,498 193 payments
Products named General payments · program years 2019–2025
  1. CINCHLOCK $1,275 10 payments
  2. N/A $1,171 13 payments
  3. CINCHLOCK SS $652 5 payments
  4. CAP-FIX $416 5 payments
  5. WasherCap Mini Fixation system 4.5mm $349 3 payments
  6. WasherCap Fixation System 10mm $349 3 payments
  7. CHAMPION $294 5 payments
  8. Bioinductive Implant with Arthroscopic Delivery System - Medium $291 3 payments
  9. HIP ARTHROSCOPY ACCESS & INSTRUMENTATION SET $284 2 payments
  10. ICONIX $232 2 payments
  11. Other $2,558 30 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 23 billing codes

Paid by Medicare

$26,398

Of which drugs: $8,555

Medicare patients

132

Average age 72

Services billed

402

61 women, 71 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 68%
Ischemic heart disease 38%
Diabetes 27%
Depression 23%
Heart failure 22%
Chronic kidney disease 17%
Osteoporosis 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, monovisc, for intra-articular injection, per dose J7327 Office 12 17 $8,547
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 17 97 $8

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

260 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record